Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug-Eluting Stents | 24 | 2020 | 681 | 2.790 |
Why?
|
Platelet Aggregation Inhibitors | 43 | 2024 | 2751 | 2.710 |
Why?
|
Absorbable Implants | 7 | 2017 | 338 | 1.970 |
Why?
|
Angioplasty, Balloon, Coronary | 15 | 2020 | 1725 | 1.820 |
Why?
|
Coronary Artery Disease | 19 | 2022 | 6403 | 1.530 |
Why?
|
Acute Coronary Syndrome | 12 | 2023 | 2190 | 1.400 |
Why?
|
Myocardial Infarction | 34 | 2023 | 11461 | 1.220 |
Why?
|
Ticlopidine | 18 | 2024 | 730 | 1.080 |
Why?
|
Coronary Thrombosis | 6 | 2017 | 440 | 1.080 |
Why?
|
China | 21 | 2021 | 2374 | 0.880 |
Why?
|
Metals | 3 | 2016 | 719 | 0.810 |
Why?
|
Cardiovascular Agents | 4 | 2015 | 840 | 0.690 |
Why?
|
Sirolimus | 10 | 2017 | 1533 | 0.690 |
Why?
|
Thrombolytic Therapy | 7 | 2021 | 2064 | 0.660 |
Why?
|
Tissue Scaffolds | 2 | 2016 | 934 | 0.640 |
Why?
|
Coronary Angiography | 12 | 2020 | 4471 | 0.620 |
Why?
|
Aspirin | 13 | 2021 | 3133 | 0.600 |
Why?
|
Purinergic P2Y Receptor Antagonists | 4 | 2023 | 284 | 0.590 |
Why?
|
Treatment Outcome | 51 | 2023 | 64684 | 0.540 |
Why?
|
Hemorrhage | 15 | 2023 | 3424 | 0.530 |
Why?
|
Coronary Disease | 6 | 2016 | 5914 | 0.530 |
Why?
|
Enoxaparin | 3 | 2007 | 391 | 0.500 |
Why?
|
Angioplasty, Balloon | 2 | 2017 | 589 | 0.480 |
Why?
|
Chromium | 1 | 2015 | 132 | 0.460 |
Why?
|
Platinum | 1 | 2015 | 220 | 0.440 |
Why?
|
Arterial Occlusive Diseases | 1 | 2017 | 748 | 0.410 |
Why?
|
Femoral Artery | 1 | 2017 | 826 | 0.410 |
Why?
|
Polymers | 4 | 2016 | 1617 | 0.400 |
Why?
|
Thrombosis | 7 | 2020 | 2942 | 0.400 |
Why?
|
Fibrinolytic Agents | 9 | 2023 | 2084 | 0.390 |
Why?
|
Drug Therapy, Combination | 12 | 2023 | 6312 | 0.380 |
Why?
|
Registries | 18 | 2022 | 8224 | 0.380 |
Why?
|
Coronary Restenosis | 5 | 2020 | 396 | 0.370 |
Why?
|
Coronary Artery Bypass | 3 | 2020 | 2188 | 0.360 |
Why?
|
Heparin | 4 | 2023 | 1634 | 0.350 |
Why?
|
Aged | 54 | 2024 | 169310 | 0.340 |
Why?
|
Ischemia | 2 | 2023 | 1883 | 0.330 |
Why?
|
Neuregulin-1 | 1 | 2010 | 135 | 0.330 |
Why?
|
Middle Aged | 66 | 2024 | 220920 | 0.320 |
Why?
|
Lower Extremity | 1 | 2017 | 1202 | 0.320 |
Why?
|
Prosthesis Design | 8 | 2018 | 2115 | 0.310 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 1516 | 0.280 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 3 | 2013 | 244 | 0.280 |
Why?
|
Male | 69 | 2024 | 360842 | 0.270 |
Why?
|
Female | 69 | 2024 | 392686 | 0.260 |
Why?
|
Receptors, Purinergic P2Y12 | 3 | 2016 | 115 | 0.250 |
Why?
|
Time Factors | 18 | 2021 | 39970 | 0.250 |
Why?
|
Postoperative Hemorrhage | 2 | 2020 | 415 | 0.250 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2020 | 3245 | 0.240 |
Why?
|
Humans | 83 | 2024 | 761572 | 0.220 |
Why?
|
Dimaprit | 1 | 2022 | 5 | 0.210 |
Why?
|
Hospital Mortality | 6 | 2020 | 5293 | 0.210 |
Why?
|
Risk Assessment | 14 | 2020 | 23996 | 0.210 |
Why?
|
Platelet Aggregation | 6 | 2017 | 771 | 0.190 |
Why?
|
Coronary Circulation | 2 | 2007 | 1569 | 0.190 |
Why?
|
Risk Factors | 22 | 2020 | 74213 | 0.190 |
Why?
|
Acute Disease | 5 | 2019 | 7237 | 0.190 |
Why?
|
Stents | 5 | 2022 | 3179 | 0.190 |
Why?
|
Thrombocytopenia | 2 | 2019 | 1182 | 0.180 |
Why?
|
Blood Platelets | 5 | 2024 | 2479 | 0.180 |
Why?
|
Research Design | 4 | 2019 | 6180 | 0.180 |
Why?
|
Calcium Channel Blockers | 2 | 2020 | 694 | 0.170 |
Why?
|
Prospective Studies | 19 | 2021 | 54426 | 0.170 |
Why?
|
Follow-Up Studies | 11 | 2020 | 39107 | 0.160 |
Why?
|
Hyperuricemia | 1 | 2022 | 222 | 0.160 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 480 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 7 | 2018 | 6484 | 0.160 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1723 | 0.150 |
Why?
|
Proportional Hazards Models | 7 | 2020 | 12463 | 0.150 |
Why?
|
Stroke | 4 | 2020 | 9758 | 0.150 |
Why?
|
Administration, Oral | 2 | 2023 | 4021 | 0.150 |
Why?
|
Methylamines | 1 | 2019 | 136 | 0.150 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12059 | 0.150 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2020 | 412 | 0.150 |
Why?
|
Peptide Fragments | 3 | 2023 | 5112 | 0.140 |
Why?
|
Angina, Unstable | 2 | 2018 | 888 | 0.140 |
Why?
|
Prognosis | 11 | 2023 | 29629 | 0.140 |
Why?
|
Drug Administration Schedule | 3 | 2020 | 4853 | 0.130 |
Why?
|
Tissue Plasminogen Activator | 2 | 2023 | 1164 | 0.130 |
Why?
|
Myocardial Ischemia | 2 | 2020 | 2113 | 0.130 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15266 | 0.130 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2021 | 2243 | 0.130 |
Why?
|
Integrin alpha2 | 1 | 2015 | 39 | 0.120 |
Why?
|
Myocardial Revascularization | 3 | 2016 | 790 | 0.120 |
Why?
|
Retreatment | 1 | 2017 | 598 | 0.120 |
Why?
|
Genotype | 5 | 2023 | 12990 | 0.120 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3826 | 0.120 |
Why?
|
Acute Kidney Injury | 1 | 2007 | 1924 | 0.120 |
Why?
|
Radiography | 2 | 2016 | 6965 | 0.120 |
Why?
|
Anticoagulants | 3 | 2023 | 4812 | 0.120 |
Why?
|
Thrombelastography | 4 | 2018 | 187 | 0.120 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7391 | 0.120 |
Why?
|
Polyesters | 1 | 2016 | 373 | 0.120 |
Why?
|
Logistic Models | 4 | 2017 | 13255 | 0.110 |
Why?
|
Contrast Media | 1 | 2007 | 5311 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1039 | 0.110 |
Why?
|
Heart Failure | 4 | 2017 | 11670 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2017 | 4176 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2019 | 809 | 0.110 |
Why?
|
Coronary Vessels | 2 | 2020 | 3096 | 0.100 |
Why?
|
Aryldialkylphosphatase | 1 | 2012 | 64 | 0.100 |
Why?
|
Proton Pump Inhibitors | 1 | 2017 | 532 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2020 | 1027 | 0.100 |
Why?
|
Asia | 2 | 2010 | 619 | 0.100 |
Why?
|
Bone Marrow Transplantation | 1 | 2019 | 2693 | 0.100 |
Why?
|
Drugs, Chinese Herbal | 1 | 2013 | 144 | 0.100 |
Why?
|
Preoperative Care | 1 | 2020 | 2242 | 0.100 |
Why?
|
Phytotherapy | 1 | 2013 | 296 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2015 | 1574 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2018 | 1116 | 0.090 |
Why?
|
Graft Occlusion, Vascular | 1 | 2014 | 537 | 0.090 |
Why?
|
Recombinant Proteins | 3 | 2023 | 6534 | 0.090 |
Why?
|
Vitamin K | 1 | 2013 | 318 | 0.090 |
Why?
|
Cohort Studies | 5 | 2020 | 41493 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2177 | 0.090 |
Why?
|
Adenosine | 1 | 2015 | 808 | 0.090 |
Why?
|
Adenosine Diphosphate | 3 | 2017 | 422 | 0.090 |
Why?
|
Patient Admission | 1 | 2017 | 1367 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1642 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2007 | 6228 | 0.080 |
Why?
|
Odds Ratio | 2 | 2017 | 9646 | 0.080 |
Why?
|
Double-Blind Method | 5 | 2019 | 12341 | 0.080 |
Why?
|
Hospitalization | 5 | 2021 | 10721 | 0.070 |
Why?
|
Age Factors | 4 | 2020 | 18398 | 0.070 |
Why?
|
Incidence | 4 | 2020 | 21355 | 0.070 |
Why?
|
Fosinopril | 1 | 2007 | 7 | 0.070 |
Why?
|
Recurrence | 2 | 2017 | 8466 | 0.070 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1533 | 0.070 |
Why?
|
Europe | 2 | 2011 | 3422 | 0.070 |
Why?
|
Coated Materials, Biocompatible | 1 | 2009 | 311 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2016 | 2822 | 0.070 |
Why?
|
Captopril | 1 | 2007 | 265 | 0.070 |
Why?
|
Platelet Function Tests | 2 | 2018 | 271 | 0.060 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58986 | 0.060 |
Why?
|
Patient Discharge | 1 | 2018 | 3443 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2016 | 15936 | 0.060 |
Why?
|
Enalapril | 1 | 2007 | 312 | 0.060 |
Why?
|
Propensity Score | 1 | 2012 | 1913 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 7967 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2007 | 679 | 0.060 |
Why?
|
Stroke Volume | 2 | 2010 | 5496 | 0.060 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15843 | 0.060 |
Why?
|
Coronary Stenosis | 1 | 2009 | 794 | 0.050 |
Why?
|
Kidney | 1 | 2019 | 7047 | 0.050 |
Why?
|
Smoking | 1 | 2020 | 9053 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1371 | 0.050 |
Why?
|
Adult | 9 | 2018 | 221203 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2017 | 80646 | 0.050 |
Why?
|
Hirudins | 1 | 2023 | 179 | 0.050 |
Why?
|
Ventricular Remodeling | 1 | 2010 | 1267 | 0.050 |
Why?
|
Platelet Count | 2 | 2019 | 781 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2013 | 4243 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6815 | 0.050 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2005 | 481 | 0.050 |
Why?
|
Probability | 1 | 2007 | 2477 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8002 | 0.050 |
Why?
|
Electrocardiography | 2 | 2020 | 6377 | 0.040 |
Why?
|
Biotransformation | 1 | 2020 | 166 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12148 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2019 | 362 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 5127 | 0.040 |
Why?
|
Cause of Death | 2 | 2019 | 3683 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7407 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2020 | 600 | 0.030 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2011 | 452 | 0.030 |
Why?
|
Drug Utilization | 1 | 2021 | 1188 | 0.030 |
Why?
|
Chronic Disease | 1 | 2010 | 9319 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2019 | 1541 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10553 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2019 | 2115 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10212 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8528 | 0.030 |
Why?
|
Survival Rate | 1 | 2007 | 12725 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1188 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15501 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6344 | 0.020 |
Why?
|
Alleles | 2 | 2013 | 6864 | 0.020 |
Why?
|
Platelet Activation | 1 | 2015 | 645 | 0.020 |
Why?
|
South America | 1 | 2011 | 179 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3416 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2015 | 567 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4124 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4303 | 0.020 |
Why?
|
Haplotypes | 1 | 2016 | 2713 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1732 | 0.020 |
Why?
|
Republic of Korea | 1 | 2011 | 590 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2013 | 897 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 3688 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2014 | 1204 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2901 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2013 | 592 | 0.020 |
Why?
|
Arachidonic Acid | 1 | 2010 | 427 | 0.020 |
Why?
|
Patient Selection | 2 | 2011 | 4244 | 0.020 |
Why?
|
North America | 1 | 2011 | 1276 | 0.020 |
Why?
|
Australia | 1 | 2011 | 1250 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1213 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 4989 | 0.020 |
Why?
|
Research | 1 | 2015 | 1982 | 0.020 |
Why?
|
Risk | 1 | 2018 | 9610 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2019 | 2917 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3358 | 0.020 |
Why?
|
Exercise Test | 1 | 2013 | 2127 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5872 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2508 | 0.010 |
Why?
|
Myocardial Reperfusion | 1 | 2005 | 338 | 0.010 |
Why?
|
Swine, Miniature | 1 | 2005 | 961 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36429 | 0.010 |
Why?
|
United States | 1 | 2010 | 72335 | 0.010 |
Why?
|
Tyrosine | 1 | 2005 | 1440 | 0.010 |
Why?
|
Random Allocation | 1 | 2005 | 2395 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20099 | 0.010 |
Why?
|
Quality Improvement | 1 | 2015 | 3801 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15732 | 0.010 |
Why?
|
Internet | 1 | 2011 | 3093 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10766 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26127 | 0.010 |
Why?
|
Comorbidity | 1 | 2011 | 10508 | 0.010 |
Why?
|
Swine | 1 | 2005 | 5915 | 0.010 |
Why?
|
Quality of Life | 1 | 2013 | 13367 | 0.010 |
Why?
|
Mutation | 1 | 2013 | 30054 | 0.000 |
Why?
|
Animals | 1 | 2005 | 168467 | 0.000 |
Why?
|
Concepts
(221)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_